Status:

COMPLETED

Reducing Cardiovascular Disease (CVD) Risk in HIV on Antiretroviral Therapy Over 12 Months

Lead Sponsor:

Holdsworth House Medical Practice

Conditions:

HIV-1 Infection

Cardiovascular Disease

Eligibility:

All Genders

50+ years

Phase:

NA

Brief Summary

This is a cohort study which follows two groups of participants over a 12 months period. One group will access a team approach to care with the aim of reducing their cardiovascular disease (CVD) risks...

Eligibility Criteria

Inclusion

  • intervention study intervention arm
  • Inclusion criteria:
  • Documented HIV-1 infection
  • Age 50 years or older
  • Stable on ART ≥ 3/12
  • Undetectable plasma HIV RNA (\< 50 copies/ml)
  • Moderate or high Framingham CVD risk score
  • Life expectancy \> 12 months
  • Regular patient under care of non-director physician
  • Willing to adhere to pharmacological CVD risk reduction intervention
  • Willing to participate in lifestyle change advice intervention
  • Exclusion criteria for intervention study
  • Life expectancy \< 1yr
  • Unable to undertake exercise
  • Drug dependency
  • Cognitive impairment affecting ability to participate in study
  • Pregnant or nursing (lactating) women, where pregnancy is defined as the state of a female after conception and until the termination of gestation, confirmed by a positive hCG laboratory test (\> 5mI U/ml)
  • Women of childbearing potential who are unwilling to use reliable contraception for the duration of the study
  • Inclusion criteria for intervention study control arm (Group 2)
  • Documented HIV-1 infection
  • Age 50 years or older
  • Stable on ART ≥3/12
  • Undetectable plasma HIV RNA (\<50 copies/ml)
  • Moderate or high Framingham risk score (\>10%)
  • Life expectancy \> 12 months
  • Regular patient under care of non-director physician

Exclusion

    Key Trial Info

    Start Date :

    October 1 2011

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    June 1 2014

    Estimated Enrollment :

    92 Patients enrolled

    Trial Details

    Trial ID

    NCT01436136

    Start Date

    October 1 2011

    End Date

    June 1 2014

    Last Update

    May 12 2015

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Holdsworth House Medical Practice

    Sydney, New South Wales, Australia, 2010